Last reviewed · How we verify
Pernazene (tymazoline)
Pernazene (generic name: tymazoline) is a tymazoline drug. It is currently in unknown development.
Tymazoline works by binding to and activating or blocking specific receptors in the body.
Pernazene is a small molecule with the synonym Tymazoline, used as a nasal decongestant to treat rhinitis. It works by reducing swelling, inflammation, and mucosal secretions through its sympathomimetic and antihistaminic properties.
At a glance
| Generic name | tymazoline |
|---|---|
| Drug class | tymazoline |
| Therapeutic area | Respiratory |
| Phase | unknown |
Mechanism of action
Think of it like a key fitting into a lock. Tymazoline is the key, and the lock is a specific receptor on a cell. When the key fits into the lock, it can either turn the lock (activate the receptor) or block it from turning (block the receptor), which can affect how the cell behaves.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pernazene CI brief — competitive landscape report
- Pernazene updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Pernazene
What is Pernazene?
How does Pernazene work?
What is the generic name of Pernazene?
What drug class is Pernazene in?
What development phase is Pernazene in?
Related
- Drug class: All tymazoline drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Respiratory
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing